UnknownNot Applicable

Comparative Assessment of Radioisotope Glucose and Breath Test

United States25 participantsStarted 2019-01-21

Plain-language summary

This is a research study about improving our diagnostic method for small intestinal bacterial overgrowth (SIBO). Patients undergoing Standard of Care (SOC) Endoscopically assisted glucose breath test (EAGBT) will undergo upper endoscopy and glucose breath tests. In this study, investigators wish to utilize Nuclear Medicine techniques to locate where the glucose solution that is administered during EAGBT is being consumed by bacteria is in the small bowel when it detects SIBO.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with recent gas, bloating, distension, and suspected SIBO * Negative oral GBT * 18 years and older Exclusion Criteria: * Pregnancy * Diabetes * Previous abdominal surgery except cholecystectomy, appendectomy * Diet prep non-adherence * Smoking or exercise causing hyperventilation prior to exam

What they're measuring

Correlation between GBT result and isotope detection in small bowel

Timeframe: February 6, 2019 (anticipated) - December 14, 2021 (anticipated)

Trial details

NCT IDNCT04499742

SponsorAugusta University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-14

Contact for this trial

Tennekoon Karunaratne, MD, PhD

7067211968 tkarunaratne@augusta.edu

View on ClinicalTrials.gov More Small Intestinal Bacterial Overgrowth trials